Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo

被引:42
|
作者
Wang, Shaoyun [1 ]
Kamat, Amrita [1 ]
Pergola, Pablo [1 ]
Swamy, Anita [1 ]
Tio, Fermin [1 ]
Cusi, Kenneth [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, Dept Med, Audie L Murphy Vet Adm Med Ctr, San Antonio, TX 78229 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2011年 / 60卷 / 08期
关键词
FATTY LIVER-DISEASE; INTRAHEPATIC TRIGLYCERIDE CONTENT; TISSUE INSULIN-RESISTANCE; PLACEBO-CONTROLLED TRIAL; ADIPOSE-TISSUE; NONALCOHOLIC STEATOHEPATITIS; PPAR-ALPHA; ADIPONECTIN RECEPTORS; WHITE ADIPOSE; LEPTIN;
D O I
10.1016/j.metabol.2010.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the study was to understand the role in vivo of elevated plasma free fatty acids (FFA), insulin, and glucose levels in the development of steatosis and altered mitochondrial gene/protein expression. We studied 4 groups of Sprague-Dawley rats: (1) high-fat diet (HFD), (2) high-dose streptozotocin-induced diabetes (T1DM), (3) low-dose streptozotocin-induced diabetic rats on an HFD (T2DM), and (4) controls. Liver histology and expression of genes/proteins related to mitochondrial fatty acid oxidation and biogenesis were analyzed. Despite an attempt to compensate by increasing expression of genes of fatty acid oxidation (carnitine palmitoyl transferase-l/medium chain acyl-CoA dehydrogenase), the HFD and diabetic groups developed marked steatosis and suffered a significant reduction in mitochondrial biogenesis gene expression (nuclear respiratory factor 11 transcriptional factor A, mitochondrial). In T2DM rats, the combination of high glucose and FFA unexpectedly did not lead to greater fat accumulation than HFD alone. Greater steatosis in HFD vs T2DM (P < .001) correlated with impairment in the gene expression of PPAR-alpha (ie, fatty acid oxidation) and PGCl alpha, a major coactivator for mitochondrial biogenesis. Steatosis was not severe in insulin-deficient T1DM rats despite very elevated FFA and glucose levels. Increased carnitine palmitoyl transferase-1/medium chain acyl-CoA dehydrogenase/PPAR-alpha gene expression suggested inadequate adaptation to high FFA in both T1DW/T2DM rats. Hyperinsulinemia combined with elevated FFA is the key metabolic factor driving hepatic lipogenesis in vivo (HFD rats). Mitochondrial biogenesis (nuclear respiratory factor 1; transcriptional factor A, mitochondrial) is highly susceptible to FFA-induced steatosis. In contrast, hyperglycemia does not have an additive effect (T2DM) and leads to only a modest degree of steatosis in the absence of hyperinsulinemia, even when FFA are extremely elevated as in T1DM rats. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1090 / 1099
页数:10
相关论文
共 50 条
  • [41] ALTERED MITOCHONDRIAL GENE EXPRESSION IN DUODENAL MUCOSA OF PATIENTS WITH DIABETIC GASTROENTEROPATHY
    Narayanan, Susrutha Puthanmadhom
    Desai, Anshuman
    O'Brien, Daniel
    Miller, Karl
    Adams, Peter D.
    Ordog, Tamas
    Bharucha, Adil E.
    GASTROENTEROLOGY, 2020, 158 (06) : S617 - S617
  • [42] Bisphenol S favors hepatic steatosis development via an upregulation of liver MCT1 expression and an impairment of the mitochondrial respiratory system
    Mornagui, Bessem
    Rezg, Raja
    Repond, Cendrine
    Pellerin, Luc
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (07) : 3057 - 3068
  • [43] Altered mitochondrial cytochrome b gene expression during the regression of hemangioma
    Hasan, Q
    Tan, ST
    Gush, J
    Davis, PF
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 108 (06) : 1471 - 1476
  • [44] Differential Effects of Diets Rich in Fats, Carbohydrates and/or Fructose on the Development of Hepatic Steatosis and Mitochondrial Dysfunction
    Garcia-Berumen, Claudia I.
    Alejandre-Buitron, Alan
    Montoya-Perez, Rocio
    Rodriguez-Orozco, Alain R.
    Calderon-Cortes, Elizabeth
    Pina-Zentella, Rosa Maria
    Ramos-Gomez, Minerva
    Saavedra-Molina, Alfredo
    Cortes-Rojo, Christian
    FASEB JOURNAL, 2016, 30
  • [45] DAILY EXERCISE ATTENUATES THE DEVELOPMENT OF HEPATIC STEATOSIS IN MICE HETEROZYGOUS FOR A MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFECT
    Rector, R. S.
    Uptergrove, Grace
    Gitan, Raad
    Ibdah, Jamal A.
    HEPATOLOGY, 2009, 50 (04) : 1173A - 1174A
  • [46] Liver gene expression in relation to hepatic steatosis and lipid secretion in two duck species
    Herault, F.
    Saez, G.
    Robert, E.
    Al Mohammad, A.
    Davail, S.
    Chartrin, P.
    Baeza, E.
    Diot, C.
    ANIMAL GENETICS, 2010, 41 (01) : 12 - 20
  • [47] PROTEASOME INHIBITOR TREATMENT REDUCES HEPATIC STEATOSIS BY DECREASING LIPOGENIC ENZYMES GENE EXPRESSION
    Oliva, J.
    French, S. W.
    Bardag-Gorce, F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 87A - 87A
  • [48] Changes in patterns of hepatic fibrinogen gene expression due to altered diet at critical phases during development.
    Zhang, J
    Byrne, CD
    ATHEROSCLEROSIS, 1998, 141 (01) : 182 - 182
  • [49] Modulation of hepatic gene expression by α-tocopherol in cultured cells and in vivo
    Rimbach, G
    Fischer, A
    Stoecklin, E
    Barella, L
    VITAMIN E AND HEALTH, 2004, 1031 : 102 - 108
  • [50] Computational Identification of Altered Metabolism Using Gene Expression and Metabolic Pathways
    Nam, Hojung
    Lee, Jinwon
    Lee, Doheon
    BIOTECHNOLOGY AND BIOENGINEERING, 2009, 103 (04) : 835 - 843